FDA's Overreach on Compounded Peptides BPC 157 FDA Approval Unlikely Due to Patent Economics Stefano M. Sinicropi, MD posted on the topic LinkedIn People are turning themselves into lab rats': the injectable peptides craze sweeping the US Well actually The Guardian FDA to weigh easing limits on unproven peptides promoted by RFK Jr. Q&A: Should you trust trending peptide injections? Big FDA review coming this July. Here's what athletes and patients should know about BPC 157, TB 500, and the broader peptide conversation. Always speak with your physician before starting any new protocol. #bpc157 #